Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis. Burggraaff, C.N., de Jong, A., Hoekstra, O.S. et al. Eur J Nucl Med Mol Imaging (2019) 46: 65
Poster and oral presentation at 6th International Workshop on PET in Lymphoma, Menton, France. Poster: 20 September 2016; Oral presentation: 21 September 2016 11:00-13:00 Poster G2: Interobserver Reproducibility of Semi-Automated Assessment of Metabolic Tumour Volume (MTV) in Diffuse Large B-cell Lymphoma (DLBCL) patients.
Oral presentation at EANM 2016, Barcelona, 19 November 2016 Interobserver Agreement of Interim 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma (DLBCL): Impact of Baseline Imaging Modality and Disease Localization. OP683 Eur J Nucl Med Mol Imaging (2016) 43 (Suppl 1):S203
Oral presentation at SNM 2017, Denver, 13 June 2017 Effect of reconstruction settings and therapy on 18F-FDG PET/CT blood pool and liver SUV in patients with diffuse large B-cell lymphoma J Nucl Med 2017 vol. 58 no. supplement 1 608
Oral presentation at 14-ICML, Lugano, 14 June 2017 Burggraaff CN, de Vet HC, Hoekstra OS, et al. FDG-PET as a Biomarker of Response in DLBCL: the HOVON 84 Study Experience. Hematological Oncology. 2017;35(S2):40–41
Oral presentation on the 7th International workshop on PET in lymphoma and myeloma, Menton, France, 4-6 October 2018 Sally F Barrington, Riekie de Vet, N George Mikhaeel, Josée Zijlstra, Coreline N Burggraaff, Corinne Eertink, Lucy C Pike, Otto S Hoekstra, Ronald Boellaard: Automated segmentation of total tumor burden segmentation in diffuse large Bcell lymphoma: which method is most successful.